SIMVASTATIN
Perioperative Care
University of Auckland, New ZealandSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Perioperative Care cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dynastat National Taiwan University Hospital | Phase 4 | BB |
Amantadine Rabin Medical Center | Phase 2 | CCC |
TESTOSTERONE UNDECYLATE London North West Healthcare NHS Trust | D |
Same molecule, other indications
SIMVASTATIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →